Skip to main content
Top
Published in: Respiratory Research 1/2021

Open Access 01-12-2021 | Tuberculosis | Research

Gene expression pattern analysis using dual-color RT-MLPA and integrative genome-wide association studies of eQTL for tuberculosis suscepitibility

Authors: Jing-Wen Ai, Hanyue Zhang, Zumo Zhou, Shanshan Weng, Heqing Huang, Sen Wang, Lingyun Shao, Yan Gao, Jing Wu, Qiaoling Ruan, Feifei Wang, Ning Jiang, Jiazhen Chen, Wenhong Zhang

Published in: Respiratory Research | Issue 1/2021

Login to get access

Abstract

Background

When infected with Mycobacterium tuberculosis, only a small proportion of the population will develop active TB, and the role of host genetic factors in different TB infection status was not fully understood.

Methods

Forty-three patients with active tuberculosis and 49 with latent tuberculosis were enrolled in the prospective cohort. Expressing levels of 27 candidate mRNAs, which were previously demonstrated to differentially expressed in latent and active TB, were measured by dual color reverse transcription multiplex ligation dependent probe amplification assay (dcRT-MLPA). Using expression levels of these mRNAs as quantitative traits, associations between expression abundance and genome-wild single nucleotide polymorphisms (SNPs) were calculated. Finally, identified candidate SNPs were further assessed for their associations with TB infection status in a validation cohort with 313 Chinese Han cases.

Results

We identified 9 differentially expressed mRNAs including il7r, il4, il8, tnfrsf1b, pgm5, ccl19, il2ra, marco and fpr1 in the prospective cohort. Through expression quantitative trait loci mapping, we screened out 8 SNPs associated with these mRNAs. Then, CG genotype of the SNP rs62292160 was finally verified to be significantly associated with higher transcription levels of IL4 in LTBI than in TB patients.

Conclusion

We reported that the SNP rs62292160 in Chinese Han population may link to higher expression of il4 in latent tuberculosis. Our findings provided a new genetic variation locus for further exploration of the mechanisms of TB and a possible target for TB genetic susceptibility studies, which might aid the clinical decision to precision treatment of TB.
Appendix
Available only for authorised users
Literature
2.
go back to reference Lillebaek T, Dirksen A, Baess I, Strunge B, Thomsen VO, Andersen AB. Molecular evidence of endogenous reactivation of Mycobacterium tuberculosis after 33 years of latent infection. J Infect Dis. 2002;185(3):401–4.CrossRef Lillebaek T, Dirksen A, Baess I, Strunge B, Thomsen VO, Andersen AB. Molecular evidence of endogenous reactivation of Mycobacterium tuberculosis after 33 years of latent infection. J Infect Dis. 2002;185(3):401–4.CrossRef
3.
go back to reference Abel L, Fellay J, Haas DW, Schurr E, Srikrishna G, Urbanowski M, et al. Genetics of human susceptibility to active and latent tuberculosis: presentknowledge and future perspectives. Lancet Infect Dis. 2018;18(3):e64-75.CrossRef Abel L, Fellay J, Haas DW, Schurr E, Srikrishna G, Urbanowski M, et al. Genetics of human susceptibility to active and latent tuberculosis: presentknowledge and future perspectives. Lancet Infect Dis. 2018;18(3):e64-75.CrossRef
4.
go back to reference Basu Roy R, Whittaker E, Seddon JA, Kampmann B. Tuberculosis susceptibility and protection in children. Lancet Infect Dis. 2019;19(3):e96-108.CrossRef Basu Roy R, Whittaker E, Seddon JA, Kampmann B. Tuberculosis susceptibility and protection in children. Lancet Infect Dis. 2019;19(3):e96-108.CrossRef
5.
go back to reference Furin J, Cox H, Pai M. Tuberculosis. Lancet (London, England). 2019;393(10181):1642–56.CrossRef Furin J, Cox H, Pai M. Tuberculosis. Lancet (London, England). 2019;393(10181):1642–56.CrossRef
6.
go back to reference Kramnik I, Demant P, Bloom BB. Susceptibility to tuberculosis as a complex genetic trait: analysis usingrecombinant congenic strains of mice. Novartis Found Symp. 1998;217(120–31):132–7. Kramnik I, Demant P, Bloom BB. Susceptibility to tuberculosis as a complex genetic trait: analysis usingrecombinant congenic strains of mice. Novartis Found Symp. 1998;217(120–31):132–7.
7.
go back to reference Comstock GW. Tuberculosis in twins: a re-analysis of the Prophit survey. Am Rev Respir Dis. 1978;117(4):621–4.PubMed Comstock GW. Tuberculosis in twins: a re-analysis of the Prophit survey. Am Rev Respir Dis. 1978;117(4):621–4.PubMed
8.
go back to reference Mistry R, Cliff JM, Clayton CL, Beyers N, Mohamed YS, Wilson PA, et al. Gene-expression patterns in whole blood identify subjects at risk for recurrenttuberculosis. J Infect Dis. 2007;195(3):357–65.CrossRef Mistry R, Cliff JM, Clayton CL, Beyers N, Mohamed YS, Wilson PA, et al. Gene-expression patterns in whole blood identify subjects at risk for recurrenttuberculosis. J Infect Dis. 2007;195(3):357–65.CrossRef
9.
go back to reference Thye T, Vannberg FO, Wong SH, Owusu-Dabo E, Osei I, Gyapong J, et al. Genome-wide association analyses identifies a susceptibility locus for tuberculosis on chromosome 18q11.2. Nat Genet. 2010;42(9):739–41.CrossRef Thye T, Vannberg FO, Wong SH, Owusu-Dabo E, Osei I, Gyapong J, et al. Genome-wide association analyses identifies a susceptibility locus for tuberculosis on chromosome 18q11.2. Nat Genet. 2010;42(9):739–41.CrossRef
10.
go back to reference Thye T, Owusu-Dabo E, Vannberg FO, van Crevel R, Curtis J, Sahiratmadja E, et al. Common variants at 11p13 are associated with susceptibility to tuberculosis. Nat Genet. 2012;44(3):257–9.CrossRef Thye T, Owusu-Dabo E, Vannberg FO, van Crevel R, Curtis J, Sahiratmadja E, et al. Common variants at 11p13 are associated with susceptibility to tuberculosis. Nat Genet. 2012;44(3):257–9.CrossRef
11.
go back to reference Zou W, Aylor DL, Zeng Z. eQTL Viewer: visualizing how sequence variation affects genome-widetranscription. BMC Bioinf. 2007;8:7.CrossRef Zou W, Aylor DL, Zeng Z. eQTL Viewer: visualizing how sequence variation affects genome-widetranscription. BMC Bioinf. 2007;8:7.CrossRef
12.
go back to reference Barreiro LB, Tailleux L, Pai AA, Gicquel B, Marioni JC, Gilad Y. Deciphering the genetic architecture of variation in the immune response to Mycobacterium tuberculosis infection. Proc Natl Acad Sci. 2012;109:1204–9.CrossRef Barreiro LB, Tailleux L, Pai AA, Gicquel B, Marioni JC, Gilad Y. Deciphering the genetic architecture of variation in the immune response to Mycobacterium tuberculosis infection. Proc Natl Acad Sci. 2012;109:1204–9.CrossRef
13.
go back to reference Siddle KJ, Deschamps M, Tailleux L, Nedelec Y, Pothlichet J, Lugo-Villarino G, et al. A genomic portrait of the genetic architecture and regulatory impact of microRNA expression in response to infection. Genome Res. 2014;24(5):850–9.CrossRef Siddle KJ, Deschamps M, Tailleux L, Nedelec Y, Pothlichet J, Lugo-Villarino G, et al. A genomic portrait of the genetic architecture and regulatory impact of microRNA expression in response to infection. Genome Res. 2014;24(5):850–9.CrossRef
14.
go back to reference Xu J , Zhu D , Shan J , Fan Y. Changes of gene expression in T lymphocytes following GolliMBP gene RNA interference. Molecular Medicine Reports, 2016. Xu J , Zhu D , Shan J , Fan Y. Changes of gene expression in T lymphocytes following GolliMBP gene RNA interference. Molecular Medicine Reports, 2016.
15.
go back to reference Wang Y, Huang G, Wang Z, Qin H, Mo B, Wang C. Elongation factor-2 kinase acts downstream of p38 MAPK to regulate proliferation, apoptosis and autophagy in human lung fibroblasts. Exp Cell Res. 2018;363(2):291–8.CrossRef Wang Y, Huang G, Wang Z, Qin H, Mo B, Wang C. Elongation factor-2 kinase acts downstream of p38 MAPK to regulate proliferation, apoptosis and autophagy in human lung fibroblasts. Exp Cell Res. 2018;363(2):291–8.CrossRef
16.
go back to reference Lawless D, Mistry A, Wood PM, Stahlschmidt J, Arumugakani G, Hull M, et al. Bialellic mutations in tetratricopeptide repeat domain 7A (TTC7A) cause common variable immunodeficiency-like phenotype with enteropathy. J Clin Immunol. 2017;37:617–22.CrossRef Lawless D, Mistry A, Wood PM, Stahlschmidt J, Arumugakani G, Hull M, et al. Bialellic mutations in tetratricopeptide repeat domain 7A (TTC7A) cause common variable immunodeficiency-like phenotype with enteropathy. J Clin Immunol. 2017;37:617–22.CrossRef
18.
go back to reference Fornage M, Jacobs DR, Steffes MW, Gross MD, Bray MS, Schreiner PJ. Inverse effects of the PPARγ2 Pro12Ala polymorphism on measures of adiposity over 15 years in African Americans and whites. The CARDIA study. Metabolism. 2005;54(7):910–7.CrossRef Fornage M, Jacobs DR, Steffes MW, Gross MD, Bray MS, Schreiner PJ. Inverse effects of the PPARγ2 Pro12Ala polymorphism on measures of adiposity over 15 years in African Americans and whites. The CARDIA study. Metabolism. 2005;54(7):910–7.CrossRef
19.
go back to reference Yu X, Zhao F, Zhang J, Pan X. Retracted article: IL-18 genetic polymorphisms may contribute to the pathogenesis of tuberculosis among Asians: a meta-analysis of case–control studies. Mol Biol Rep. 2014;41(9):6013–23.CrossRef Yu X, Zhao F, Zhang J, Pan X. Retracted article: IL-18 genetic polymorphisms may contribute to the pathogenesis of tuberculosis among Asians: a meta-analysis of case–control studies. Mol Biol Rep. 2014;41(9):6013–23.CrossRef
20.
go back to reference Han M, Yue J, Lian Y, Zhao Y, Wang H, Liu L. Relationship between single nucleotide polymorphism of interleukin-18 and susceptibility to pulmonary tuberculosis in the Chinese Han population. Microbiol Immunol. 2011;55(6):388–93.CrossRef Han M, Yue J, Lian Y, Zhao Y, Wang H, Liu L. Relationship between single nucleotide polymorphism of interleukin-18 and susceptibility to pulmonary tuberculosis in the Chinese Han population. Microbiol Immunol. 2011;55(6):388–93.CrossRef
21.
go back to reference Zhang G, Zhou B, Wang W, Zhang M, Zhao Y, Wang Z, et al. A functional single-nucleotide polymorphism in the promoter of the gene encoding interleukin 6 is associated with susceptibility to tuberculosis. J Infect Dis. 2012;205(11):1697–704.CrossRef Zhang G, Zhou B, Wang W, Zhang M, Zhao Y, Wang Z, et al. A functional single-nucleotide polymorphism in the promoter of the gene encoding interleukin 6 is associated with susceptibility to tuberculosis. J Infect Dis. 2012;205(11):1697–704.CrossRef
23.
go back to reference Jansen PR, Watanabe K, Stringer S, Skene N, Bryois J, Hammerschlag AR, et al. Genome-wide analysis of insomnia in 1,331,010 individuals identifies new riskloci and functional pathways. Nat Genet. 2019;51(3):394–403.CrossRef Jansen PR, Watanabe K, Stringer S, Skene N, Bryois J, Hammerschlag AR, et al. Genome-wide analysis of insomnia in 1,331,010 individuals identifies new riskloci and functional pathways. Nat Genet. 2019;51(3):394–403.CrossRef
24.
go back to reference Qiu C, Huang S, Park J, Park Y, Ko Y, Seasock MJ, et al. Renal compartment-specific genetic variation analyses identify new pathways in chronic kidney disease. Nat Med. 2018;24(11):1721–31.CrossRef Qiu C, Huang S, Park J, Park Y, Ko Y, Seasock MJ, et al. Renal compartment-specific genetic variation analyses identify new pathways in chronic kidney disease. Nat Med. 2018;24(11):1721–31.CrossRef
25.
go back to reference Zhang W, Bojorquez-Gomez A, Velez DO, Xu G, Sanchez KS, Shen JP, et al. A global transcriptional network connecting noncoding mutations to changes intumor gene expression. Nat Genet. 2018;50(4):613–20.CrossRef Zhang W, Bojorquez-Gomez A, Velez DO, Xu G, Sanchez KS, Shen JP, et al. A global transcriptional network connecting noncoding mutations to changes intumor gene expression. Nat Genet. 2018;50(4):613–20.CrossRef
26.
go back to reference Darboe F, Adetifa JU, Reynolds J, Hossin S, Plebanski M, Netea MG, et al. Minimal sex-differential modulation of reactivity to pathogens and toll-likereceptor ligands following infant Bacillus Calmette-Guerin Russia Vaccination. Front Immunol. 2017;8:1092.CrossRef Darboe F, Adetifa JU, Reynolds J, Hossin S, Plebanski M, Netea MG, et al. Minimal sex-differential modulation of reactivity to pathogens and toll-likereceptor ligands following infant Bacillus Calmette-Guerin Russia Vaccination. Front Immunol. 2017;8:1092.CrossRef
27.
go back to reference Malik A, Gupta M, Mani R, Bhatnagar R. Single-dose Ag85B-ESAT6-loaded poly(lactic-co-glycolic acid) nanoparticles conferprotective immunity against tuberculosis. Int J Nanomed. 2019;14:3129–43.CrossRef Malik A, Gupta M, Mani R, Bhatnagar R. Single-dose Ag85B-ESAT6-loaded poly(lactic-co-glycolic acid) nanoparticles conferprotective immunity against tuberculosis. Int J Nanomed. 2019;14:3129–43.CrossRef
28.
go back to reference Jenum S, Dhanasekaran S, Lodha R, Mukherjee A, Kumar Saini D, Singh S, et al. Approaching a diagnostic point-of-care test for pediatric tuberculosis throughevaluation of immune biomarkers across the clinical disease spectrum. Sci Rep-UK. 2016a;6:18520.CrossRef Jenum S, Dhanasekaran S, Lodha R, Mukherjee A, Kumar Saini D, Singh S, et al. Approaching a diagnostic point-of-care test for pediatric tuberculosis throughevaluation of immune biomarkers across the clinical disease spectrum. Sci Rep-UK. 2016a;6:18520.CrossRef
29.
go back to reference Mihret A, Loxton AG, Bekele Y, Kaufmann SHE, Kidd M, Haks MC, et al. Combination of gene expression patterns in whole blood discriminate betweentuberculosis infection states. BMC Infect Dis. 2014;14:257.CrossRef Mihret A, Loxton AG, Bekele Y, Kaufmann SHE, Kidd M, Haks MC, et al. Combination of gene expression patterns in whole blood discriminate betweentuberculosis infection states. BMC Infect Dis. 2014;14:257.CrossRef
30.
go back to reference Jenum S, Dhanasekaran S, Lodha R, Mukherjee A, Kumar Saini D, Singh S, et al. Approaching a diagnostic point-of-care test for pediatric tuberculosis through evaluation of immune biomarkers across the clinical disease spectrum. Sci Rep-UK. 2016b. https://doi.org/10.1038/srep18520.CrossRef Jenum S, Dhanasekaran S, Lodha R, Mukherjee A, Kumar Saini D, Singh S, et al. Approaching a diagnostic point-of-care test for pediatric tuberculosis through evaluation of immune biomarkers across the clinical disease spectrum. Sci Rep-UK. 2016b. https://​doi.​org/​10.​1038/​srep18520.CrossRef
31.
go back to reference Chavez-Galan L, Vesin D, Uysal H, Blaser G, Benkhoucha M, Ryffel B, et al. Transmembrane tumor necrosis factor controls myeloid-derived suppressor cell activity via TNF receptor 2 and protects from excessive inflammation during BCG-induced pleurisy. Front Immunol. 2017;8:999.CrossRef Chavez-Galan L, Vesin D, Uysal H, Blaser G, Benkhoucha M, Ryffel B, et al. Transmembrane tumor necrosis factor controls myeloid-derived suppressor cell activity via TNF receptor 2 and protects from excessive inflammation during BCG-induced pleurisy. Front Immunol. 2017;8:999.CrossRef
32.
go back to reference Chavez-Galan L, Vesin D, Segueni N, Prasad P, Buser-Llinares R, Blaser G, et al. Tumor necrosis factor and its receptors are crucial to control Mycobacteriumbovis Bacillus Calmette-Guerin pleural infection in a murine model. Am J Pathol. 2016;186(9):2364–77.CrossRef Chavez-Galan L, Vesin D, Segueni N, Prasad P, Buser-Llinares R, Blaser G, et al. Tumor necrosis factor and its receptors are crucial to control Mycobacteriumbovis Bacillus Calmette-Guerin pleural infection in a murine model. Am J Pathol. 2016;186(9):2364–77.CrossRef
33.
go back to reference Jiao Y, Li Y, Jiang P, Han W, Liu Y. PGM5: a novel diagnostic and prognostic biomarker for liver cancer. Peer J. 2019;7:e7070.CrossRef Jiao Y, Li Y, Jiang P, Han W, Liu Y. PGM5: a novel diagnostic and prognostic biomarker for liver cancer. Peer J. 2019;7:e7070.CrossRef
34.
go back to reference Tokunaga R, Naseem M, Lo JH, Battaglin F, Soni S, Puccini A, et al. B cell and B cell-related pathways for novel cancer treatments. Cancer Treat Rev. 2019;73:10–9.CrossRef Tokunaga R, Naseem M, Lo JH, Battaglin F, Soni S, Puccini A, et al. B cell and B cell-related pathways for novel cancer treatments. Cancer Treat Rev. 2019;73:10–9.CrossRef
35.
go back to reference Novakowski KE, Yap NVL, Yin C, Sakamoto K, Heit B, Golding GB, et al. Human-specific mutations and positively selected sites in MARCO Confer functional changes. Mol Biol Evol. 2018;35(2):440–50.CrossRef Novakowski KE, Yap NVL, Yin C, Sakamoto K, Heit B, Golding GB, et al. Human-specific mutations and positively selected sites in MARCO Confer functional changes. Mol Biol Evol. 2018;35(2):440–50.CrossRef
36.
go back to reference Schepetkin IA, Khlebnikov AI, Kirpotina LN, Quinn MT. Antagonism of human formyl peptide receptor 1 with natural compounds and their synthetic derivatives. Int Immunopharmacol. 2016;37:43–58.CrossRef Schepetkin IA, Khlebnikov AI, Kirpotina LN, Quinn MT. Antagonism of human formyl peptide receptor 1 with natural compounds and their synthetic derivatives. Int Immunopharmacol. 2016;37:43–58.CrossRef
37.
go back to reference Weber B, Schaper C, Wang Y, Scholz J, Bein B. Interaction of the ubiquitin carboxyl terminal esterase L1 with alpha(2)-adrenergic receptors inhibits agonist-mediated p44/42 MAP kinase activation. Cell Signal. 2009;21(10):1513–21.CrossRef Weber B, Schaper C, Wang Y, Scholz J, Bein B. Interaction of the ubiquitin carboxyl terminal esterase L1 with alpha(2)-adrenergic receptors inhibits agonist-mediated p44/42 MAP kinase activation. Cell Signal. 2009;21(10):1513–21.CrossRef
38.
go back to reference Kondratenko TI, Kuzina NV, Severin ES, Kornilova ZK, Perel’man MI. Alpha-adrenergic receptors of the human lung parenchyma in destructive tuberculosis. Vopr Med Khim. 1991;37:69–70.PubMed Kondratenko TI, Kuzina NV, Severin ES, Kornilova ZK, Perel’man MI. Alpha-adrenergic receptors of the human lung parenchyma in destructive tuberculosis. Vopr Med Khim. 1991;37:69–70.PubMed
39.
go back to reference Bao J, Huang Y, Wang F, Peng Y, Qiu Y. Expression of alpha-AR subtypes in T lymphocytes and role of the alpha-ARs inmediating modulation of T cell function. NeuroImmunoModulation. 2007;14(6):344–53.CrossRef Bao J, Huang Y, Wang F, Peng Y, Qiu Y. Expression of alpha-AR subtypes in T lymphocytes and role of the alpha-ARs inmediating modulation of T cell function. NeuroImmunoModulation. 2007;14(6):344–53.CrossRef
40.
go back to reference Rojas M, Olivier M, Garcia LF. Activation of JAK2/STAT1-alpha-dependent signaling events during Mycobacteriumtuberculosis-induced macrophage apoptosis. Cell Immunol. 2002;217(1–2):58–66.CrossRef Rojas M, Olivier M, Garcia LF. Activation of JAK2/STAT1-alpha-dependent signaling events during Mycobacteriumtuberculosis-induced macrophage apoptosis. Cell Immunol. 2002;217(1–2):58–66.CrossRef
41.
go back to reference Hasan Z, Shah BH, Mahmood A, Young DB, Hussain R. The effect of mycobacterial virulence and viability on MAP kinase signalling and TNF alpha production by human monocytes. Tuberculosis (Edinburgh, Scotland). 2003;83(5):299–309.CrossRef Hasan Z, Shah BH, Mahmood A, Young DB, Hussain R. The effect of mycobacterial virulence and viability on MAP kinase signalling and TNF alpha production by human monocytes. Tuberculosis (Edinburgh, Scotland). 2003;83(5):299–309.CrossRef
42.
go back to reference Rojas M, Garcia LF, Nigou J, Puzo G, Olivier M. Mannosylated lipoarabinomannan antagonizes Mycobacterium tuberculosis-induced macrophage apoptosis by altering Ca+2-dependent cell signaling. J Infect Dis. 2000;182(1):240–51.CrossRef Rojas M, Garcia LF, Nigou J, Puzo G, Olivier M. Mannosylated lipoarabinomannan antagonizes Mycobacterium tuberculosis-induced macrophage apoptosis by altering Ca+2-dependent cell signaling. J Infect Dis. 2000;182(1):240–51.CrossRef
Metadata
Title
Gene expression pattern analysis using dual-color RT-MLPA and integrative genome-wide association studies of eQTL for tuberculosis suscepitibility
Authors
Jing-Wen Ai
Hanyue Zhang
Zumo Zhou
Shanshan Weng
Heqing Huang
Sen Wang
Lingyun Shao
Yan Gao
Jing Wu
Qiaoling Ruan
Feifei Wang
Ning Jiang
Jiazhen Chen
Wenhong Zhang
Publication date
01-12-2021
Publisher
BioMed Central
Published in
Respiratory Research / Issue 1/2021
Electronic ISSN: 1465-993X
DOI
https://doi.org/10.1186/s12931-020-01612-9

Other articles of this Issue 1/2021

Respiratory Research 1/2021 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine